An existing drug already used to treat other conditions could potentially be used to treat patients who have newly been diagnosed with type 1 diabetes . The drug, Rituxa, is currently used to treat rheumatoid arthritis and Hodgkin’s Lymphoma.
The potential type 1 diabetes drug is produced by Genentech – a unit of Roche Holding AG and Biogen Idec Inc. The diabetes drug could help patients to produce their own insulin, even if the pancreatic beta cells have already been attacked and destroyed.
The drug is currently under trial for diabetic use. Dr. Mark Pescovitz, the lead researcher of the study, was reported as saying: “What this study does is open the door to a whole new way to approaching type 1 diabetes.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…